Inactive Instrument

Insiders Pediatrx Inc OTC Bulletin Board

Equities

US70532X1072

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

07/05	IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.	CI
06/05	Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Theralink Technologies, Inc. Announces Chief Executive Officer Changes	27/23/27	CI
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer	27/23/27	CI
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary	12/23/12	CI
Theralink Technologies Appoints Michael Vallone as Senior Director of Commercialization	09/23/09	CI
Theralink Technologies, Inc. Appoints Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company	06/22/06	CI
Theralink Technologies, Inc. Appoints Mattia Cremona as Its Director of Its Biopharma Laboratory	07/22/07	CI
Theralink Technologies, Inc. Announces Board Appointments	06/22/06	CI
OncBioMune Pharmaceuticals, Inc. Announces Executive Changes	12/20/12	CI
OncBioMune Pharmaceuticals, Inc. Announces Management Changes	12/20/12	CI
OncBioMune Pharmaceuticals, Inc. Appoints Andrew Kucharchuk as Director	01/20/01	CI
OncBioMune Pharmaceuticals Appoints Mitesh J. board as Scientific Advisory Board	28/19/28	CI
OncBioMune Pharmaceuticals, Inc. Announces Management Changes	28/18/28	CI
OncBioMune Pharmaceuticals, Inc. Appoints Robert Neal Holcomb to Board of Directors	19/18/19	CI
Manuel Cosme Odabachian Resigns as Member of the Board of Directors of OncBioMune Pharmaceuticals, Inc	30/17/30	CI
OncBioMune Pharmaceuticals, Inc. Announces Executive Changes	13/17/13	CI
Anuel Cosme Odabachian to Join OncBioMune Pharmaceuticals as an executive officer	10/16/10	CI
OncBioMune Pharmaceuticals, Inc. Appoints Brian Barnett to its Scientific Advisory Board	24/16/24	CI
OncBiomune Pharmaceuticals Appoints J. Jacques Carter to its Scientific Advisory Board	22/16/22	CI
OncBioMune Pharmaceuticals, Inc. Elects Daniel S. Hoverman as Member of the Board	05/16/05	CI
OncBioMune Pharmaceuticals Appoints Charles Rice, Jr. to its Board of Directors	19/15/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Pediatrx Inc OTC Bulletin Board

Equities

US70532X1072

Insiders

Filters